Explore evidence

0.9 %Genotyping detected R561H mutation at a frequency of 0.9% in the Kelch 13 (Pfk13) gene.

Kenyapaludismepublished 2025Malaria journalPubMeddocument of 12 observations

30 per_100Antibody prevalence in adults was low (< 30%) for SE and circumsporozoite protein (CSP).

Kenyapaludismepublished 2020The American journal of tropical medicine and hygienePubMeddocument of 3 observations

Time to symptom resolution was similar between COVID-19 patients with malaria co-infection (median 9 days [IQR 5–13]) and those without (median 10 days [IQR 6–13]), with adjusted hazard ratio 1.14 (95% CI 0.91–1.42; p=0.26).

KenyaCOVID-19 · paludismepublished 2026The Lancet. Global healthPubMeddocument of 8 observations

7 %The vaccine efficacy of RTS,S/AS01 against clinical malaria was 7.0% in the per-protocol analysis over 7 years of follow-up.

Kenyapaludismepublished 2016The New England journal of medicineeurope_pmcdocument of 4 observations

32.1 %Spatial repellents reduced the hazard rate of overall new malaria infections by 32.1% (95% CI 15.9-45.2; p=0.0004).

Kenyapaludismepublished 2025Lancet (London, England)PubMeddocument of 4 observations

Children 1–5 years of age were more likely to carry microscopically detectable gametocytes than their older counterparts in a cohort from Kilifi county, Kenya.

Kenyapaludismepublished 2019Wellcome open researcheurope_pmcdocument of 5 observations

21.2 %Nationally, there was an 88% reduction in the mean modelled Plasmodium falciparum parasite prevalence among children aged 2–10 years (PfPR 2-10) in Kenya from 21.2% in 1990 to 2.6% in 2015.

Kenyapaludismeobserved 1990published 2018Malaria journaleurope_pmcdocument of 2 observations

72 deaths_per_dayEvery day in Kenya approximately 72 children below the age of 5 years die from malaria.

Kenyapaludismepublished 1998Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 4 observations

0.74 odds_ratioIn 2011–2013, individuals who stated that they slept under ITNs as compared with those who did not had a decrease in malaria incidence that approached statistical significance (OR 0.74, 95% CI: 0.52–1.04, p = 0.08).

Kenyapaludismeobserved 2011–2013published 2020The American journal of tropical medicine and hygienePubMeddocument of 3 observations

98 %98% of the samples had dhfr mutations at positions N51I, C59R, or S108N alleles in Busia County, Western Kenya.

Kenyapaludismepublished 2025Malaria journalPubMeddocument of 6 observations

14 outletsStaff adhered to the national malaria treatment guidelines in 14 out of 70 retail drug outlets.

Kenyapaludismeobserved 2021published 2023Malaria journalPubMeddocument of 8 observations

50 per_100Malaria transmission was high in Cameroon compared to Kenya and Ethiopia with over 50% of the infected bites recorded outdoors.

Cameroun · Éthiopie · Kenyapaludismepublished 2021The Journal of infectious diseaseseurope_pmcdocument of 4 observationsDOI 10.1093/infdis/jiaa774

135.2 infective_bites_per_person_per_yearThe lakeshore zone had an inoculation rate of 135.2 infective bites/person/year.

Kenyapaludismeobserved 2020published 2022Parasites & vectorsPubMeddocument of 6 observations

44 %44% of artesunate-treated malaria patients were prescribed ACT follow-on treatment.

Kenyapaludismeobserved April 2019published 2020Malaria journaleurope_pmcdocument of 20 observations

10 %The prevalence of varATS-detectable asymptomatic Plasmodium falciparum infections was 10% in Webuye.

Kenyapaludismepublished 2021Malaria journalPubMeddocument of 6 observations

63.5 %Malaria prevalence was highest among 5–9 year olds at 63.5% in a cross-sectional survey conducted in 2008 in four contiguous villages in Mulanda sub-county, Tororo district, eastern Uganda.

Kenyapaludismeobserved 2008published 2010Malaria journaleurope_pmcdocument of 6 observationsDOI 10.1186/1475-2875-9-2

55 %At two sites malaria admission rates increased by 55% and 35%.

Kenyapaludismepublished 2010Malaria journaleurope_pmcdocument of 3 observationsDOI 10.1186/1475-2875-9-285

49.43 %The human blood index (HBI) of Anopheles funestus was 49.43% and significantly higher compared to 3.44% for Anopheles arabiensis in the irrigated study site.

Kenyapaludismepublished 2022Parasitology researchPubMeddocument of 7 observations

54.6 %The negative predictive value of the ultrasensitive RDT for detecting P. falciparum parasitaemia was 54.6% in asymptomatic children aged 7–14 years in western Kenya.

Kenyapaludismepublished 2022Malaria journalPubMeddocument of 6 observations

4 %In west and central Africa, very low sulfadoxine-pyrimethamine resistance was categorised as a prevalence of the dihydropteroate synthase (dhps) Lys540Glu mutation in the parasite population of less than 4%.

Kenyapaludismepublished 2025The Lancet. Infectious diseaseseurope_pmcdocument of 13 observations

13.2 per_1000From 2003 to 2010, in children under 5 years in western Kenya, the malaria mortality rate decreased from 13.2 to 3.7 per 1,000 person-years.

Kenyapaludismeobserved 2003-2010published 2014PloS oneeurope_pmcdocument of 3 observations

5,753 individualsBlood samples were obtained from 5753 individuals in Kenyan highland area with low and seasonal malaria transmission in 2007 and episodes of clinical malaria were recorded in this population from 2007 to 2017.

Kenyapaludismeobserved 2007published 2025Malaria journalPubMeddocument of 8 observations

367 × 10⁹ platelets/lMean platelet counts were elevated in eBL cases versus controls among malaria-negative subjects (367 vs. 339 × 10⁹ platelets/l, P < 0.001).

Kenyaendemic Burkitt lymphoma · paludismeobserved 2010-2016published 2020British journal of haematologyPubMeddocument of 4 observations

4 yearAntibodies to IE surface antigens expressing virulent phenotypes had a half-life of 4–10 years.

Kenyapaludismepublished 2017The Journal of infectious diseaseseurope_pmcdocument of 7 observationsDOI 10.1093/infdis/jix370

45.8 %At 15 months follow-up, RTS,S/AS01E vaccine efficacy against first or only clinical malaria episode was 45.8%.

Kenyapaludismepublished 2011The Lancet. Infectious diseaseseurope_pmcdocument of 6 observationsDOI 10.1016/s1473-3099(10)70262-0